WOLVERINE ASSET MANAGEMENT LLC - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 52 filers reported holding BIOTECH ACQUISITION COMPANY in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$2,536,125
+1.8%
251,1040.0%0.03%
-3.7%
Q3 2022$2,492,000
+0.3%
251,1040.0%0.03%
+8.0%
Q2 2022$2,485,000
+51.9%
251,104
+51.3%
0.02%
+56.2%
Q1 2022$1,636,000
+0.4%
165,934
+0.2%
0.02%
+6.7%
Q4 2021$1,630,000
-5.2%
165,653
-6.2%
0.02%0.0%
Q3 2021$1,720,000
-4.2%
176,607
-4.9%
0.02%
+7.1%
Q2 2021$1,796,000
+11125.0%
185,775
+11004.3%
0.01%
Q1 2021$16,0001,6730.00%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q2 2021
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$7,930,0002.58%
Corbin Capital Partners, L.P. 928,124$9,207,0002.29%
Cohanzick Management, LLC 799,001$7,926,0001.92%
RPO LLC 379,021$3,762,0000.91%
Arena Capital Advisors, LLC- CA 300,000$2,978,0000.90%
Alpha Wave Global, LP 532,570$5,286,0000.62%
MIZUHO SECURITIES USA LLC 444,957$4,383,0000.60%
MMCAP International Inc. SPC 599,321$5,945,0000.47%
GLAZER CAPITAL, LLC 2,285,000$22,667,0000.42%
CVI Holdings, LLC 292,563$2,904,0000.22%
View complete list of BIOTECH ACQUISITION COMPANY shareholders